Clinical Trial Update: A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating albuferon in combination with ribavirin for interferon-naive adults with chronic hepatitis C genotype 1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Albuferon (albuferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: Human Genome Sciences Inc. | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED